1
|
Huang L, Hong Z, Guo Y, Song W, Huang J, Cao W, Cao C, Chen R, Bai Z. Association of Vegetable and Fruit Consumption Patterns with Cognitive Function in Older People with Different BMI Ranges: Findings from China. Clin Interv Aging 2025; 20:587-596. [PMID: 40371124 PMCID: PMC12077408 DOI: 10.2147/cia.s515094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2024] [Accepted: 05/06/2025] [Indexed: 05/16/2025] Open
Abstract
Purpose There is a lack of research on how vegetable and fruit consumption patterns affect cognitive function in older adults with varying BMIs. Therefore, this study aims to explore their relationship, with a special focus on gender differences. Patients and Methods A cross-sectional survey was conducted in Anhui Province, China, between July and September 2019, and information was collected from 6211 participants regarding socio-demographics, the frequency of vegetable and fruit consumption per week, and cognitive function. The study utilized descriptive analysis and binary logistic regression to determine the association between cognitive function and consumption patterns of vegetable and fruit. Results There were no statistically significant associations between vegetable and fruit consumption patterns and cognitive function in underweight and obese older adults. Among normal weight men, older adults in the V+/F- (AOR=1.65; 95% CI: 1.16-2.35) and V-/F- (AOR=3.95; 95% CI: 1.86-8.42) groups were more likely to have cognitive impairment compared with the V+/F+ group. However, no associations were observed between the two in women of normal weight. For the overweight women, a higher risk of cognitive impairment was found in the V+/F- group (AOR=1.54; 95% CI: 1.12-2.11), while older men did not. Conclusion The correlation between vegetable and fruit consumption patterns and cognitive function varies among older adults with different BMIs. Findings suggest the need for targeted nutritional interventions for these communities to maintain cognitive function in older adults.
Collapse
Affiliation(s)
- Liang Huang
- Department of Medical Affairs Management, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, People’s Republic of China
| | - Zixuan Hong
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| | - Ying Guo
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| | - Wenjin Song
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| | - Jiawei Huang
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| | - Wenwen Cao
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| | - Chenglin Cao
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| | - Ren Chen
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
- Department of Geriatrics, Chaohu Hospital of Anhui Medical University, Chaohu, Anhui, People’s Republic of China
| | - Zhongliang Bai
- Department of Health Services Management, School of Health Services Management, Anhui Medical University, Hefei, Anhui, People’s Republic of China
| |
Collapse
|
2
|
Gheni G, Shinohara M, Masuda‐Suzukake M, Shindo A, Watanabe A, Kawai K, Bu G, Tomimoto H, Hasegawa M, Sato N. Cerebral hypoperfusion reduces tau accumulation. Ann Clin Transl Neurol 2025; 12:69-85. [PMID: 39621511 PMCID: PMC11752094 DOI: 10.1002/acn3.52247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2024] [Revised: 10/03/2024] [Accepted: 10/24/2024] [Indexed: 01/22/2025] Open
Abstract
OBJECTIVE Alzheimer's disease (AD) often coexists with cerebrovascular diseases. However, the impact of cerebrovascular diseases such as stroke on AD pathology remains poorly understood. METHODS This study examines the correlation between cerebrovascular diseases and AD pathology. The research was carried out using clinical and neuropathological data collected from the National Alzheimer's Coordinating Center (NACC) database and an animal model in which bilateral common carotid artery stenosis surgery was performed, following the injection of tau seeds into the brains of wild-type mice. RESULTS Analysis of the NACC database suggests that clinical stroke history and lacunar infarcts are associated with lower neurofibrillary tangle pathology. An animal model demonstrates that chronic cerebral hypoperfusion reduces tau pathology, which was observed in not only neurons but also astrocytes, microglia, and oligodendrocytes. Furthermore, we found that astrocytes and microglia were activated in response to tau pathology and chronic cerebral hypoperfusion. Additionally, cerebral hypoperfusion increased a lysosomal enzyme, cathepsin D. INTERPRETATION These data together indicate that cerebral hypoperfusion reduces tau accumulation likely through an increase in microglial phagocytic activity towards tau and an elevation in degradation through cathepsin D. This study contributes to understanding the relationship between tau pathology and cerebrovascular diseases in older people with multimorbidity.
Collapse
Grants
- MEXT15K15272 Grants-in-Aid from Japan Promotion of Science; the Japanese Ministry of Education, Culture, Sports, Science, and Technology
- 19-9 Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology
- P20 AG068053 NIA NIH HHS
- P30 AG062421 NIA NIH HHS
- Takeda Medical Research Foundation Research
- P30 AG066508 NIA NIH HHS
- P30 AG072973 NIA NIH HHS
- P30 AG066530 NIA NIH HHS
- Novartis Foundation for Gerontological Research Award
- P30 AG066509 NIA NIH HHS
- P30 AG066546 NIA NIH HHS
- Mitsui Sumitomo Insurance Welfare Foundation
- P30 AG072979 NIA NIH HHS
- P20 AG068082 NIA NIH HHS
- P30 AG072975 NIA NIH HHS
- P30 AG066444 NIA NIH HHS
- P30 AG066507 NIA NIH HHS
- P30 AG072946 NIA NIH HHS
- P30 AG066518 NIA NIH HHS
- P30 AG066511 NIA NIH HHS
- U24 AG072122 NIA NIH HHS
- MEXT21H02844 Grants-in-Aid from Japan Promotion of Science; the Japanese Ministry of Education, Culture, Sports, Science, and Technology
- P30 AG066512 NIA NIH HHS
- MEXT26293167 Grants-in-Aid from Japan Promotion of Science; the Japanese Ministry of Education, Culture, Sports, Science, and Technology
- P30 AG066515 NIA NIH HHS
- P30 AG072978 NIA NIH HHS
- P30 AG062429 NIA NIH HHS
- P30 AG066519 NIA NIH HHS
- Takeda Science Foundation Research Encouragement Grant
- 28-45 Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology
- P30 AG062422 NIA NIH HHS
- R01 AG079280 NIA NIH HHS
- P30 AG066462 NIA NIH HHS
- 19-3 Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology
- 21-12 Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology
- MEXT24K02361 Grants-in-Aid from Japan Promotion of Science; the Japanese Ministry of Education, Culture, Sports, Science, and Technology
- P20 AG068077 NIA NIH HHS
- P30 AG072977 NIA NIH HHS
- P30 AG062677 NIA NIH HHS
- P20 AG068024 NIA NIH HHS
- P30 AG072958 NIA NIH HHS
- P30 AG062715 NIA NIH HHS
- P30 AG066506 NIA NIH HHS
- P30 AG066468 NIA NIH HHS
- Annual Research Award Grant from the Japanese Society of Anti-aging Medicine
- P30 AG072976 NIA NIH HHS
- P30 AG072947 NIA NIH HHS
- P30 AG072931 NIA NIH HHS
- MEXT17H04154 Grants-in-Aid from Japan Promotion of Science; the Japanese Ministry of Education, Culture, Sports, Science, and Technology
- SENSHIN Medical Research Foundation Research Grant
- P30 AG072972 NIA NIH HHS
- P30 AG066514 NIA NIH HHS
- P30 AG072959 NIA NIH HHS
- 24-16 Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology
- Mitsui Sumitomo Insurance Welfare Foundation
Collapse
Affiliation(s)
- Ghupurjan Gheni
- Department of Aging Neurobiology, Center for Development of Advanced Medicine for DementiaNational Center for Geriatrics and Gerontology7‐430 MoriokaObuAichi474‐8511Japan
| | - Mitsuru Shinohara
- Department of Aging Neurobiology, Center for Development of Advanced Medicine for DementiaNational Center for Geriatrics and Gerontology7‐430 MoriokaObuAichi474‐8511Japan
- Department of NeuroscienceMayo ClinicJacksonvilleFlorida32224USA
| | - Masami Masuda‐Suzukake
- Dementia Research ProjectTokyo Metropolitan Institute of Medical Science2‐1‐6 Kamikitazawa, Setagaya‐kuTokyo156‐8506Japan
| | - Akihiko Shindo
- Department of Neurology, Graduate School of MedicineMie University1577 Kurima MachiyachoTsu CityMie514‐8507Japan
| | - Atsushi Watanabe
- Equipment Management Division, Center for Core Facility Administration, National Center for Geriatrics and Gerontology7‐430 MoriokaObuAichi474‐8511Japan
| | - Kaori Kawai
- Department of Aging Neurobiology, Center for Development of Advanced Medicine for DementiaNational Center for Geriatrics and Gerontology7‐430 MoriokaObuAichi474‐8511Japan
| | - Guojun Bu
- Department of NeuroscienceMayo ClinicJacksonvilleFlorida32224USA
- Division of Life ScienceThe Hong Kong University of Science and TechnologyHong KongChina
| | - Hidekazu Tomimoto
- Department of Neurology, Graduate School of MedicineMie University1577 Kurima MachiyachoTsu CityMie514‐8507Japan
| | - Masato Hasegawa
- Dementia Research ProjectTokyo Metropolitan Institute of Medical Science2‐1‐6 Kamikitazawa, Setagaya‐kuTokyo156‐8506Japan
| | - Naoyuki Sato
- Department of Aging Neurobiology, Center for Development of Advanced Medicine for DementiaNational Center for Geriatrics and Gerontology7‐430 MoriokaObuAichi474‐8511Japan
| |
Collapse
|
3
|
Zhao Z, Yang X, Dorn S, Miao J, Barcellos SH, Fletcher JM, Lu Q. Controlling for polygenic genetic confounding in epidemiologic association studies. Proc Natl Acad Sci U S A 2024; 121:e2408715121. [PMID: 39432782 PMCID: PMC11536117 DOI: 10.1073/pnas.2408715121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Accepted: 09/20/2024] [Indexed: 10/23/2024] Open
Abstract
Epidemiologic associations estimated from observational data are often confounded by genetics due to pervasive pleiotropy among complex traits. Many studies either neglect genetic confounding altogether or rely on adjusting for polygenic scores (PGS) in regression analysis. In this study, we unveil that the commonly employed PGS approach is inadequate for removing genetic confounding due to measurement error and model misspecification. To tackle this challenge, we introduce PENGUIN, a principled framework for polygenic genetic confounding control based on variance component estimation. In addition, we present extensions of this approach that can estimate genetically unconfounded associations using GWAS summary statistics alone as input and between multiple generations of study samples. Through simulations, we demonstrate superior statistical properties of PENGUIN compared to the existing approaches. Applying our method to multiple population cohorts, we reveal and remove substantial genetic confounding in the associations of educational attainment with various complex traits and between parental and offspring education. Our results show that PENGUIN is an effective solution for genetic confounding control in observational data analysis with broad applications in future epidemiologic association studies.
Collapse
Affiliation(s)
- Zijie Zhao
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI53706
| | - Xiaoyu Yang
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI53706
| | - Stephen Dorn
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI53706
| | - Jiacheng Miao
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI53706
| | - Silvia H. Barcellos
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA90089
- Department of Economics, University of Southern California, Los Angeles, CA90089
| | - Jason M. Fletcher
- La Follette School of Public Affairs, University of Wisconsin-Madison, Madison, WI53706
| | - Qiongshi Lu
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI53706
- Department of Statistics, University of Wisconsin-Madison, Madison, WI53706
| |
Collapse
|
4
|
Christensen A, McGill CJ, Qian W, Pike CJ. Effects of obesogenic diet and 17β-estradiol in female mice with APOE 3/3, 3/4, and 4/4 genotypes. Front Aging Neurosci 2024; 16:1415072. [PMID: 39347015 PMCID: PMC11427389 DOI: 10.3389/fnagi.2024.1415072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Accepted: 08/26/2024] [Indexed: 10/01/2024] Open
Abstract
The main genetic risk factor for Alzheimer's disease (AD) is the apolipoprotein E ε4 allele (APOE4). AD risk associated with APOE4 disproportionately affects women. Furthermore, human and rodent studies indicate that the cognitive deficits associated with APOE4 are greater in females. One modifiable AD risk factor is obesity during middle age. Given that approximately two-thirds of US adults are overweight, it is important to understand how obesity affects AD risk, how it interacts with APOE4, and the extent to which its detrimental effects can be mitigated with therapeutics. One intervention study for women is estrogen-based hormone therapy, which can exert numerous health benefits when administered in early middle age. No experimental studies have examined the interactions among APOE4, obesity, and hormone therapy in aging females. To begin to explore these issues, we considered how obesity outcomes are affected by treatment with estradiol at the onset of middle age in female mice with human APOE3 and APOE4. Furthermore, to explore how gene dosage affects outcomes, we compared mice homozygous for APOE3 (3/3) and homozygous (4/4) or hemizygous (3/4) for APOE4. Mice were examined over a 4-month period that spans the transition into reproductive senescence, a normal age-related change that models many aspects of human perimenopause. Beginning at 5 months of age, mice were maintained on a control diet (10% fat) or high-fat diet (HFD; 60% fat). After 8 weeks, by which time obesity was present in all HFD groups, mice were implanted with an estradiol or vehicle capsule that was maintained for the final 8 weeks. Animals were assessed on a range of metabolic and neural measures. Overall, APOE4 was associated with poorer metabolic function and cognitive performance. However, an obesogenic diet induced relatively greater impairments in metabolic function and cognitive performance in APOE3/3 mice. Estradiol treatment improved metabolic and cognitive outcomes across all HFD groups, with APOE4/4 generally exhibiting the greatest benefit. APOE3/4 mice were intermediate to the homozygous genotypes on many measures but also exhibited unique profiles. Together, these findings highlight the importance of the APOE genotype as a modulator of the risks associated with obesity and the beneficial outcomes of estradiol.
Collapse
Affiliation(s)
| | | | | | - Christian J. Pike
- Davis School of Gerontology, University of Southern California, Los Angeles, CA, United States
| |
Collapse
|
5
|
Nicolas L, Bassien-Capsa V, Ancedy Y, Chingan-Martino V, Clotilde JP, Afassinou YM, Galantine O, Fanhan R, Tabué-Teguo M, Foucan L. Associations between Cognitive Impairment, Weight Status and Comorbid Conditions in Hospitalized Adults of 55 Years and Older in Guadeloupe. Healthcare (Basel) 2024; 12:1712. [PMID: 39273736 PMCID: PMC11395463 DOI: 10.3390/healthcare12171712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Revised: 08/20/2024] [Accepted: 08/22/2024] [Indexed: 09/15/2024] Open
Abstract
Cognitive decline and comorbid conditions commonly co-occur, and these conditions can affect cognitive health. We aimed to estimate the prevalence of cognitive impairment (CI) according to weight status and to evaluate the associations between CI, weight status and comorbid conditions in adults of 55 years and older. The Abbreviated Mental Test Score (AMTS) was used. Logistic regressions were performed. Overall, 415 individuals were included. The mean age was 75.7 ± 10.1 years, and the mean BMI was 26.2 ± 6.9 kg/m2. The prevalence of CI was 20.7% in the whole study group and 31%, 24.8%, 17.7% and 10.2% in underweight, normal weight, overweight and obese individuals, respectively; p < 0.004. The low folate, vitamin D and prealbumin levels were more frequently found in individuals with CI compared with those without CI. Compared with the obese individuals, a higher odds ratio of prevalent CI was noted for underweight individuals OR 3.89 (95% CI 1.54-9.80); p = 0.004. Additionally, male gender, older age, stroke, having three or more comorbid conditions and findings of undernutrition were significantly associated with CI. Being underweight was associated with an increased risk of CI. Prevention strategies including the monitoring of nutritional status may help to prevent cognitive decline and promote healthy aging.
Collapse
Affiliation(s)
- Livy Nicolas
- Medical Unit, Médical Centre Lucien NICOLAS, Clinique Nouvelles Eaux Marines, Le Moule 97160, Guadeloupe
- Research Team on Cardiometabolic Risk ECM, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Valerie Bassien-Capsa
- Research Team on Cardiometabolic Risk ECM, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Yann Ancedy
- Medical Unit, Médical Centre Lucien NICOLAS, Clinique Nouvelles Eaux Marines, Le Moule 97160, Guadeloupe
- Cardiology Unit, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Vaneva Chingan-Martino
- Diabetic Foot Unit, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Jean-Pierre Clotilde
- Medical Unit, Médical Centre Lucien NICOLAS, Clinique Nouvelles Eaux Marines, Le Moule 97160, Guadeloupe
| | - Yaovi Mignazonzon Afassinou
- Research Team on Cardiometabolic Risk ECM, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Olivier Galantine
- Research Team on Cardiometabolic Risk ECM, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Rosan Fanhan
- Medical Unit, Médical Centre Lucien NICOLAS, Clinique Nouvelles Eaux Marines, Le Moule 97160, Guadeloupe
| | - Maturin Tabué-Teguo
- Laboratoire de Mathématique Informatique et Applications LAMIA (EA 4540), University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
| | - Lydia Foucan
- Research Team on Cardiometabolic Risk ECM, University Hospital, University of the Antilles, Pointe-à-Pitre 97157, Guadeloupe
- Clinical Research Unit, Médical Centre Lucien NICOLAS, Clinique Nouvelles Eaux Marines, Le Moule 97160, Guadeloupe
| |
Collapse
|
6
|
Zhang T, Wang P, Li R, Wang Y, Yan S. Correlation between obesity and Alzheimer 's disease and the mechanisms. ZHONG NAN DA XUE XUE BAO. YI XUE BAN = JOURNAL OF CENTRAL SOUTH UNIVERSITY. MEDICAL SCIENCES 2024; 49:1052-1061. [PMID: 39788493 PMCID: PMC11495975 DOI: 10.11817/j.issn.1672-7347.2024.240025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Indexed: 01/12/2025]
Abstract
Alzheimer's disease (AD) is a progressive central neurodegenerative disorder with an insidious onset. With global aging, the incidence and mortality of AD have been steadily increasing, yet effective treatments remain elusive. Obesity, characterized by excessive or abnormal fat accumulation, is a complex metabolic disorder and a confirmed risk factor for numerous diseases. Both obesity and AD have become major public health concerns, posing significant threats to human health and economic development. Studies have revealed a strong correlation between obesity and AD, with multiple contributing factors, including metabolic abnormalities of endocrine factors, inflammatory responses, and genetic interactions. Exploring the correlation and mechanisms between obesity and AD provides important insights and new strategies for the prevention and treatment of AD.
Collapse
Affiliation(s)
- Tenglin Zhang
- Second Ward of Endocrinology Department, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000.
- First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000.
| | - Ping Wang
- Second Ward of Endocrinology Department, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000
| | - Ruonan Li
- Second Ward of Endocrinology Department, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000
- First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000
| | - Ying Wang
- Department of Geriatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
| | - Shuxun Yan
- Second Ward of Endocrinology Department, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000.
| |
Collapse
|
7
|
Zhao Z, Yang X, Miao J, Dorn S, Barcellos SH, Fletcher JM, Lu Q. Controlling for polygenic genetic confounding in epidemiologic association studies. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.02.12.579913. [PMID: 38405812 PMCID: PMC10888957 DOI: 10.1101/2024.02.12.579913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/27/2024]
Abstract
Epidemiologic associations estimated from observational data are often confounded by genetics due to pervasive pleiotropy among complex traits. Many studies either neglect genetic confounding altogether or rely on adjusting for polygenic scores (PGS) in regression analysis. In this study, we unveil that the commonly employed PGS approach is inadequate for removing genetic confounding due to measurement error and model misspecification. To tackle this challenge, we introduce PENGUIN, a principled framework for polygenic genetic confounding control based on variance component estimation. In addition, we present extensions of this approach that can estimate genetically-unconfounded associations using GWAS summary statistics alone as input and between multiple generations of study samples. Through simulations, we demonstrate superior statistical properties of PENGUIN compared to the existing approaches. Applying our method to multiple population cohorts, we reveal and remove substantial genetic confounding in the associations of educational attainment with various complex traits and between parental and offspring education. Our results show that PENGUIN is an effective solution for genetic confounding control in observational data analysis with broad applications in future epidemiologic association studies.
Collapse
Affiliation(s)
- Zijie Zhao
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI
| | - Xiaoyu Yang
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI
| | - Jiacheng Miao
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI
| | - Stephen Dorn
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI
| | - Silvia H. Barcellos
- Center for Economic and Social Research (CESR), University of Southern California, Los Angeles, CA
- Department of Economics, University of Southern California, Los Angeles, CA
| | - Jason M. Fletcher
- La Follette School of Public Affairs, University of Wisconsin-Madison, Madison, WI
| | - Qiongshi Lu
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI
- Department of Statistics, University of Wisconsin-Madison, Madison, WI
| |
Collapse
|